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Phytochemicals are the bioactive components that contribute to the prevention of cardiovascular and other degenerative diseases.
Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase would be an effective means of lowering plasma
cholesterol in humans.The present study explores the HMGCoA reductase inhibitory effect of extracts from leaves ofMorus indica
varieties, M5, V1, and S36, compared with the statin, using an ex vivomethod. The assay is based on the stoichiometric formation
of coenzyme A during the reduction of microsomal HMG CoA to mevalonate. Dechlorophyllised extract of three varieties was
studied at 300 𝜇g. The coenzyme A released at the end of assay in control (100.31 nmoles) and statins (94.46 nm) was higher
than the dechlorphyllised extracts of the samples. The coenzyme A released during the reduction of HMG CoA to mevalonate
in dechlorophyllised extracts of the samples was as follows: S36 < M5 < V1. The results indicated that the samples were highly
effective in inhibiting the enzyme compared to statins (standard drug). The results indicate the role ofMorus varieties extracts in
modulating the cholesterol metabolism by inhibiting the activity of HMGCoA reductase.These results provide scope for designing
in vivo animal studies to confirm their effect.
1. Introduction
Cholesterol as a constituent of all eukaryotic plasma mem-
branes is essential for the growth and viability of higher
organisms. For healthy statue cholesterol homeostasis is very
important and is accomplished by a regulatory complex
network [1]. The hypercholesterolemia and elevated LDL-C
(LDL-cholesterol) concentration are the major risk factors
for the development of atherosclerosis and coronary heart
disease [2]. In this consequence, reducing plasma cholesterol
levels is one of the major aims of public health organizations
[3]. Hydroxy-3-methylglutaryl coenzyme A reductase (HMG
CoA reductase) is the rate-limiting step in the biosynthesis
of cholesterol in humans; inhibition of this enzyme would
be an effective means of lowering plasma cholesterol. Drugs
like statins, fibrates, niacin, and so forth are used to lower
cholesterol. Due to the prevalence of these drugs adverse
effects, search was made for an alternative natural drug [4].
Medicinal plants are good sources of therapeutic com-
ponents and their use for medical purposes has a long
history. Over past years, extracts of medicinal plants have
gained increasing importance as a source of herbal drugs
[5]. Exploration of the chemical constituents of the plants
and pharmacological screening will thus provide the basis
for developing new life saving drugs and functional foods.
HMG CoA reductase inhibitors have been identified from
many herbs, medicinal plants, microorganisms, and so forth.
Phytochemicals such as phenolics, flavonoids, terpenoids,
saponins, and alkaloids are the bioactive components present
at microlevel in our daily diet and have received much
attention in disease treatment due to their in vivo and in vitro
antioxidant capabilities [6].
Many studies have reported the hypocholesterolemic
property of medicinal plants at biological level [7–9]. Some
studies have also reported the ex vivo inhibition of HMG
CoA reductase activity by herbs specially medicinal plants,
namely, Quercus infectoria, Rosa damascene, Myrtus com-
munis, Andrographis paniculata, Anthocephalus indicus, and
Ocimum sanctum [10]. Our team has explored the antiox-
idant properties and potency of the phytochemicals and
polyphenols of differentmedicinal plants fromwestern Ghats
on ex vivo inhibition of the HMG CoA reductase activity
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[11–15] and hypocholesterolemic effect of Moringa oleifera
leaf powder in animal models [7].
Morus indica (Mulberry tree) of the family Moraceae
has been widely cultivated in countries all over the world
including temperate to tropical areas. It is nontoxic natural
therapeutic agent and different parts of the plant shown
to possess hypoglycemic, hypotensive, cholesterol and lipid
peroxides reduction, antiphlogistic, diuretic properties and
expectorant effects. It occupies an important position in the
holistic system of Indian medicine “Ayurveda” which has its
roots in antiquity and has been practiced for centuries. The
leaves of mulberry are nutritious, palatable, nontoxic, and
also enriched with different active principles [16–18].
Reports indicate Morus as a good source of phyto-
chemicals and various solvent extracts of its leaves showed
varying degrees of antioxidant activity in both in vitro and
ex vivo models. Also, the extracts have exhibited stability
to high temperature and different pH [19, 20]. Few reports
are available on the antihyperglycemic and antioxidant effect
of Morus leaves in streptozotocin-induced diabetic rats. The
Morus effectively reduced the increased oxidative stress in
diabetic rats and the leaves exerted a rapid protective effect
against lipid peroxidation by scavenging O
2
− (superoxide)
and elevating the activities of antioxidant enzymes by virtue
of antioxidant flavonoids (quercetins) [21, 22]. In another
study, Morus therapy to human subjects with diabetes has
resulted in a significant decrease in the concentration of
serum total cholesterol, triglycerides, plasma free fatty acids,
LDL-cholesterol, VLDL-cholesterol, plasma peroxides, and
urinary peroxides, while increasing HDL-cholesterol, and
also in diabetic rats reduced the retinopathy [16, 17]. The
available literature indicates the antidiabetic and antioxi-
dant properties of Morus. However, studies on the hypoc-
holesterolemic effect are lacking and studies are needed to
prove its efficacy at biological level especially in cholesterol
metabolism in animals. As an initiative, preclinical studies
have been undertaken to study the ability of Morus varieties
to inhibit HMG CoA reductase, a key enzyme in cholesterol
metabolism. The Morus extracts were compared with the
commercial hypocholesterolemic drug, Atorvastatin.
2. Materials and Methods
2.1. Chemicals. All the chemicals were of analytical grade.
HMG CoA, dithiothreitol, triethanolamine, and NADPH
were obtained from Sigma Aldrich Chemicals, Bangalore.
2.2. Plant Material. Three varieties of Morus indica (MI),
namely, M1, V1, and S36 leaves, collected from Central Ser-
icultural Research and Training Institute (CSRTI), Mysore,
and identified by Dr. Shivamurthy, Department of Studies
in Botany, University of Mysore, and voucher specimen was
retained in the laboratory for future.The collected leaves were
washed and dried in a hot air oven at 55∘C. Dry leaves were
ground separately and passed through a 60 𝜇m mesh sieve
and kept in air-tight containers at 4∘C until further use.
2.3. Preparation of Dechlorophyllised Extract. 15 g sample
of each sample was extracted separately with 100mL 80%
methanol (methanol 80mL and water 20mL). To avoid
the interference of chlorophyll, it was separated as per the
method of Rich A and Rich C [23]. Briefly, hexane was added
to the 80% methanol extract and shaken for 30min and the
chlorophyll-rich hexane top layer was separated.The remain-
ing extract was further evaporated (Rotary evaporator) and
oven-dried (50∘C) and stored in air-tight container at 0∘C
until used.
2.4. Preparation of Microsomes. A healthy male adult rat
was obtained from the Central Animal House, Department
of Zoology, University of Mysore, after availing clearance
from the University Animal Ethics Committee of University
of Mysore (number MGZ/2620/2011-12; dtd: 31.01.2012). The
rat was fasted for 24 hrs and sacrificed after 9:00 pm to
obtain the active HMG CoA reductase enzyme. The liver
was immediately removed from the rat and placed in cold
triethanolamine HCl buffer (0–4∘C) at pH 7.4. The liver
was thoroughly chilled and homogenized. The homogenate
was centrifuged at 60,000 g for 60min; the supernatant was
separated and microsomal pellet was then rinsed with buffer
and frozen at −20∘C. The resuspended microsomes to be
used for the assay were diluted with buffer to give a protein
concentration of 5–10mg/mL. The procedure described here
is partially modified from that reported by Shapiro and
Rodwell, 1971 [24].
2.5. 3-Hydroxy-3-methylglutaryl CoA Reductase Assay. For
the assay of 3-hydroxy-3-methylglutaryl CoA reductase,
the incubation mixtures contain 0.5–1.0mg of microso-
mal protein, 150 nmoles of HMG CoA, and 2 𝜇moles of
NADPH. These components are added to 0.8mL of 0.1M
triethanolamine-0.02M EDTA buffer at pH 7.4 without
dithiothreitol.The dithiothreitol (0.2𝜇mole) was added along
with the microsomal preparation. The final incubation vol-
ume was 1mL. Contents in tubes were as follows: (a) all
components, (b) all components except NADPH, (c) all
components except NADPH with 300 𝜇g of Morus leaves
extracts separately, and (d) all components except NADPH
with statins (Atorvastatin-10𝜇g) [25]. After a series of steps,
the coenzyme A released was calculated using the following
formula:
nmoles /min = [A reaction − A control] × 1.43
0.0136 × time
. (1)
The value of 1.43 is the dilution factor, andA is the absorbance
at 412 nm.Thedifference in absorbance between the complete
reaction and that of all components except NADPH repre-
sents the activity due to HMG CoA reductase.
2.6. Statistical Analysis. Each experiment was conducted in
triplicates and data are expressed as mean ± SD.The data was
subjected to Student t-test (𝑃 ≤ 0.05).
3. Results
In the present study, liver microsomes were treated with
dechlorophyllised extracts (300 𝜇g) of three Morus indica
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Figure 1: Percent inhibition of HMG CoA reductase by Morus
indica varieties Ctrl—control; Stns—Atorvastatin (10𝜇g); M5—
300 𝜇g; V1—300 𝜇g; S36 - 300 𝜇g. (𝑃 ≤ 0.05).
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Figure 2: Effect ofMorus indica on the activity of HMGCoA reduc-
tase and release of coenzyme. Ctrl—control; Stns—Atorvastatin
(10𝜇g); M5—300 𝜇g; V1—300 𝜇g; S36—300 𝜇g.
varieties (M5,V1, and S36) and their effect on the activity of 3-
hydroxy-3-methylglutaryl CoA reductase was measured.The
assaywas run against a control and comparedwith the statins.
The results indicate that all the three extracts were highly
effective (63–67%) compared to statins (37%) in inhibiting
the HMG CoA reductase in the liver microsomes (Figure 1).
The coenzyme A released during the assay was higher in
control (100.31 nmoles) than in the microsomes treated with
Morus and statins (Figures 2 and 3) and, among all, S36 was
more potent in inhibiting the enzyme activity (48.52 nmoles).
Figure 2 shows the time course of activity of HMG CoA
reductase for a period of 4th min; it can be observed that
the rate of release of coenzyme A was constantly increasing
from zeroth to 4th min, both in control and statins. In M5,
the coenzyme A released at zeroth min (M5—48.36 nmoles)
was higher than other samples and statins. At the end of
4th min, the rate of release of coenzyme A was less in M5
(50.47 nmoles) than in the control (100.31 nmoles), statins
(94.46 nmoles), and V1 (54.76 nmoles). In case of the other
two varieties, that is, V1 and S36, the coenzyme A released
at zero min was less (V1—17.36 and S36—25.55 nmoles) than
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Figure 3: Total coenzyme A (nmoles/mg protein) released during
the reduction of HMG CoA to mevalonate. Ctrl—control; Stns—
Atorvastatin (10 𝜇g); Ctrl—control; Stns—Atorvastatin (10𝜇g);
M5—300 𝜇g; V1—300 𝜇g; S36—300 𝜇g.
the other samples and rate of release of coenzyme was high in
first 2min and decreased from 2nd to 4th min. However, the
rate of release of coenzyme A in all the samples, statins, and
control was high in first 2ndmin and decreased from 2nd to
4th min.
Figure 3 shows the total HMG Co A reductase activity as
nmoles of coenzyme A released at the end of 4th min in the
order of control (100.31 nmoles) > statins (94.46 nmoles) >
V1 (54.76 nmoles)>M5 (50.47 nmoles)> S36 (48.52 nmoles).
The low amount of CoA released by Morus varieties is
indicative of the inhibitory effect on HMG CoA reductase.
4. Discussion
Cholesterol is an insoluble lipid molecule that plays a critical
role in the structure and function of membrane bilayers.
Membrane cholesterol contents that are either too high or
too low are detrimental to cell function. When present in
excess amounts in cells, cholesterol becomes toxic. Certainly,
cholesterol-induced cytotoxicity represents a key initiating
event leading to the development of atherosclerotic cardio-
vascular disease [26].
Statins are the most commonly administered class of
drugs to lower plasma LDL-cholesterol.Their primarymech-
anism of action is to promote clearance of LDL particles
from the plasma.This is accomplished because statins reduce
the rate of intracellular cholesterol synthesis by inhibit-
ing 3-hydroxy-3-methylglutaryl (HMG) CoA reductase, the
rate-limiting step in cholesterol biosynthesis [27]. However,
most commercial HMG CoA reductase inhibitors have
shown adverse effects including the induction of cutaneous
vasodilatation, rashes, gastrointestinal discomfort, and hype-
ruricemia [28].
In our laboratory,Morus indica has been investigated for
its antioxidant, antidiabetic, and antimicrobial effects [18, 19,
21, 29]. Oral administration ofMorus leaf powder (500mg/kg
b.w) produced a significant hypoglycaemic effect in STZ-
induced diabetic rats. The concurrent effect of Morus indica
on lipid metabolism was significant in diabetic rats; this was
evidenced by the reductions in serum cholesterol, triglyc-
erides, and lipid peroxides [30]. However, the mechanism
involved in the cholesterol lowering byMorus indica leaf has
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not been reported. Hence, an attempt was made to study the
inhibitory effect of leaves from three Morus indica varieties
(300 𝜇g) on HMG CoA reductase activity using a simple ex
vivomodel system comprising of liver microsomes. In the rat
liver microsomes, a cell-free system,Morus indica extracts of
leaves effectively theHMGCoA reductase activity better than
the statins and control. This is the first report on the ex vivo
inhibition of HMG CoA reductase byMorus indica.
The enzyme inhibitory effect correlates with the medici-
nal properties and phytochemical components such as phe-
nol compounds, alkaloids, and saponins. All three Morus
varieties are good sources of phytochemicals and dechloro-
phyllised extract was rich in polyphenol content [20]. Par-
ticularly, S36 with more phytochemical composition have
inhibited the HMG CoA reductase with more potency than
the other two varieties (M5 an V1). A similar result was
reported in Moringa oleifera polyphenol extract on HMG
CoA reductase inhibition, in a dose-dependent manner [12].
3-Hydroxy-3-methylglutaryl coenzyme A reductase, the
enzyme that synthesizes mevalonate, appears to be regulated
through a multivalent feedback mechanism. Full suppression
of the reductase requires the presence of at least two reg-
ulators: cholesterol, which is normally derived exogenously
from plasma low density lipoprotein (LDL), and a nonsterol
product, which is normally synthesized endogenously from
mevalonate [31]. In culturedmammalian cells such as human
fibroblasts, the activity of HMGCoA reductase and hence the
formation of mevalonate are controlled through a feedback
mechanism mediated by cholesterol that enters cells bound
to a plasma lipoprotein, low density lipoprotein (LDL). In the
absence of plasma LDL, cells in culture synthesize their own
cholesterol, maintaining high levels of HMG CoA reductase.
This effect was demonstrated by adding LDL to the culture
medium.The LDL-derived cholesterol reduced the activity of
HMGCoA reductase, thereby turning off the cell’s cholesterol
synthesis [32, 33]. In the present study, Morus extracts and
statins might have acted in a similar manner as LDL in
inhibiting HMG CoA reductase, thus preventing formation
of mevalonate.
Although several medicinal plants have been reported to
possess cholesterol lowering properties, no data is reported
on the cholesterol loweringmechanism [9, 34–38].Themajor
metabolic pathway for reducing cholesterol is via conversion
to bile acids or preventing the cholesterol synthesis by
inhibiting the HMG CoA reductase enzyme. To establish
the cholesterol lowering mechanism of Morus, we are also
exploring its bile acid binding capacity using in vitro model
system. Such preclinical studies will help in proper selection
of medicinal plants for promoting their therapeutic utility.
5. Conclusion
The findings of the present study provide preliminary data
that suggest that Morus indica is capable of reducing choles-
terol levels by inhibiting the HMG CoA reductase activity
in hyperlipidemic condition. The study also lends support
to the reported data on the hypocholesterolemic role of
Morus indica in diabetic condition. Promoting the utilization
of Morus leaves appears to be beneficial as it can play
an important role in the prevention and management of
cardiovascular diseases.
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